aristada’s activity in the body is due to aripiprazole and also dehydro-aripiprazole. dehydro-aripirazole has been shown to have affinities for d2 receptors. these d2 receptors have similarities to aripiprazole whereas they represent 30-40% of exposure of aripiprazole in plasma.